🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Prostate Cancer Screening

INSIDE: Identification of Genomic Screening Pathways in Cancer Patients With DNA Repair Alterations NCT06334809n/a2 sites📍 Candiolo📍 Orbassano Fondazione del Piemonte per l'Oncologia The Man Van Project NCT06357416NA1 site📍 London Royal Marsden NHS Foundation Trust · Tests: MV-POCT Sub-study, Main Man Van Group Sub-study (MV-Eco), MV-QualQ Sub-study, MV-PRS Sub-study, MV-DNA and MV-UctDNA Su… Cleveland African American Prostate Cancer Project NCT05469269NA1 site📍 Cleveland Case Comprehensive Cancer Center · Tests: Passive Education, Education by Community Navigator, Education at Community Outreach Screening Event Prostate Cancer Genetic Risk Evaluation and Screening Study NCT05129605n/a1 site📍 Boston Massachusetts General Hospital · Tests: Prostate cancer screening cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease NCT05366881n/a17 sites📍 Duarte📍 Miami📍 Gainesville Adela, Inc Comparing Standard of Care Biopsy System to a Novel Biopsy Needle System by Computational Pathologic Analysis NCT06830265NA3 sites📍 New York📍 Durham📍 Hardeeville Uro-1 Medical · Tests: Novel needle biopsy catheter (test) The i4i PRODICT® Study: Evaluation of the i4i PRODICT® Test in Different Ethnic Groups (The i4i PRODICT® Study). NCT06636526n/a3 sites📍 Sutton📍 London📍 Sutton Institute of Cancer Research, United Kingdom · Tests: The i4i PRODICT® test., Prostate cancer screening, MRI Scan, Prostate Biopsy Evaluation of an MRI-based Prostate Cancer Screening Program (VISIONING): 5-Year Follow-up Round (VISIONING III) NCT07762911NA1 site📍 Basel University Hospital, Basel, Switzerland · Tests: MRI Establishment and Promotion of an AI-Based Early Warning System for Prostate and Bladder Cancer Screening in the Male Community Population of Beijing NCT07319923n/a1 site📍 Beijing Peking University First Hospital · Tests: No intervention To Identify Potential New Urine Markers for the Screening of Prostate Cancer NCT03914391n/a1 site📍 Shatin Chinese University of Hong Kong Polygenic Risk Stratification Combined With mpMRI to Identify Clinically Relevant Prostate Cancer NCT06398639NA5 sites📍 Washington D.C.📍 Bethesda📍 Bethesda Adam S. Kibel, MD · Tests: Polygenic Risk Score (PRS) The PROFILE Study: Germline Genetic Profiling: Correlation With Targeted Prostate Cancer Screening and Treatment NCT02543905n/a1 site📍 Sutton Institute of Cancer Research, United Kingdom · Tests: Prostate MRI and Biopsy Building on Trust: Navigating Preventive Lung, Breast, and Prostate Cancer Screenings at Community Resource Spots NCT07231159n/a1 site📍 Orlando AdventHealth · Tests: referral for definitive diagnosis based on their cancer screening results, Engagement Connect2Care: Prostate Cancer Education and Screenings for African American Men NCT07055165NA1 site📍 Oklahoma City University of Oklahoma · Tests: Prostate Cancer Genius App, US Prevention Taskforce App Accurate Prostate Cancer Following Using Low-Field MRI (Low-PRISM) NCT06482489n/a1 site📍 Lausanne University of Lausanne Hospitals · Tests: Siemens Magnetom Free.Max 0.55T (Siemens Healthineers, Erlangen, Germany). Urine Prostate Screening Integrated With MRI for Early Detection of Prostate Cancer, UPRISE Trial NCT07526545NA1 site📍 Ann Arbor University of Michigan Rogel Cancer Center · Tests: Biopsy Procedure, Diagnostic Procedure, Electronic Health Record Review, Magnetic Resonance Imaging Screening and Staging of Benign vs Malignant Pelvic Abnormalities NCT07407959n/a1 site📍 Rochester Mayo Clinic · Tests: Non-Interventional Study Utility of Biparametric MRI (Magnetic Resonance Imaging) as a Screening Tool for Prostate Cancer in a High-Risk Cohort NCT05384535NA1 site📍 Lake Success Northwell Health · Tests: Bi-parametric MRI Danish Prostate Cancer Consortium Study-1 NCT05767307n/a3 sites📍 Aarhus N📍 Hellerup📍 Odense Aarhus University Hospital Screening for Prostate Cancer Using High Resolution Micro-ultrasound Versus Multiparametric Magnetic Resonance Imaging. NCT06626022Phase 39 sites📍 Los Angeles📍 Dallas📍 Edmonton University of Alberta · Tests: MRI, ExactVu PSMA PET/MRI-Guided Prostate Biopsy for PI-RADS ≤3 and Prior Negative Biopsy NCT06923657NA1 site📍 Fuzhou First Affiliated Hospital of Fujian Medical University · Tests: PSMA PET/MRI-TRUS guided prostate targeted combined saturation biopsy, TRUS guided transperineal saturation biopsy The Prostate Cancer, Genetic Risk, and Equitable Screening Study (ProGRESS) NCT05926102NA1 site📍 Boston VA Office of Research and Development · Tests: Precision screening intervention, Usual care The Vanguard Study: Testing a New Way to Screen for Cancer NCT06995898NA45 sites📍 Pleasanton📍 Cheyenne Wells📍 Denver National Cancer Institute (NCI) · Tests: Biospecimen Collection, Device Usage, Electronic Health Record Review, Multi-Cancer Detection Test, Multi-Cancer Detect… Prostate Cancer Screening for People at Genetic Risk for Aggressive Disease, PATROL Study NCT04472338n/a8 sites📍 Duarte📍 San Francisco📍 Chicago University of Washington · Tests: Biospecimen Collection, Laboratory Biomarker Analysis, Quality-of-Life Assessment, Questionnaire Administration Upright MRI for Prostate Cancer Screening NCT03474913n/a1 site📍 New York Icahn School of Medicine at Mount Sinai · Tests: Upright MRI, Standard MRI The CCANED-CIPHER Study: Early Cancer Detection and Treatment Response Monitoring Using AI-Based Platelet and Immune Cell Transcriptomic Profiling NCT06717295n/a4 sites📍 Rosario📍 Lagos📍 Cambridge Javier Toledo · Tests: DiNanoQ: A multi-cancer early detection (MCED) blood test, DiNanoTrack: Therapeutic Response Monitoring Blood Test Decipher Lethal Prostate Cancer Biology - Urine Metabolomics NCT03237702NA1 site📍 Taipei National Taiwan University Hospital · Tests: Multi-Carotenoids Lab Research Using Mini-tumors to Study Prostate Cancer Treatments NCT07004582n/a3 sites📍 Heerlen📍 Maastricht📍 Maastricht Maastricht Radiation Oncology · Tests: HDR brachytherapy, Diagnostic biopsy Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection NCT05334069n/a747 sites📍 Anchorage📍 Anchorage📍 Anchorage Alliance for Clinical Trials in Oncology · Tests: Questionnaire Administration, Biospecimen Collection Impact of an Electronic Health Record Maintenance Alert on PSA Screening Rates in a 10-Hospital Integrated Health System NCT07109427NA1 site📍 St Louis Washington University School of Medicine · Tests: Annual PSA Health Maintenance Reminder
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy